These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Novel therapeutic applications of cardiac glycosides. Prassas I; Diamandis EP Nat Rev Drug Discov; 2008 Nov; 7(11):926-35. PubMed ID: 18948999 [TBL] [Abstract][Full Text] [Related]
8. Interactions between cardiac glycosides and sodium/potassium-ATPase: three-dimensional structure-activity relationship models for ligand binding to the E2-Pi form of the enzyme versus activity inhibition. Paula S; Tabet MR; Ball WJ Biochemistry; 2005 Jan; 44(2):498-510. PubMed ID: 15641774 [TBL] [Abstract][Full Text] [Related]
9. The cardiac glycosides of Thevetia ovata A.DC. and Thevetia nereifolia Juss. ex Stend. Kyerematen G; Hagos M; Weeratunga G; Sandberg F Acta Pharm Suec; 1985; 22(1):37-44. PubMed ID: 2992232 [No Abstract] [Full Text] [Related]
10. [Effect of cardiac glycosides on myocardial metabolism during cardiac insufficieny]. Sokolov EI; Oreshuk FA Farmakol Toksikol; 1967; 30(6):684-8. PubMed ID: 5598436 [No Abstract] [Full Text] [Related]
11. [Recent acquisitions in the study of the pharmacology of cardiac glycosides. Pharmacokinetic approach to therapy with cardiac glycosides]. Lesne M J Pharm Belg; 1973; 28(2):217-33. PubMed ID: 4733470 [No Abstract] [Full Text] [Related]
12. [Role of calcium ions and the participation of the mitochondria in realizing the positive inotropic action of cardiac glycosides (a review of the literature)]. Denisov IuP Farmakol Toksikol; 1980; 43(6):740-5. PubMed ID: 6256209 [No Abstract] [Full Text] [Related]
13. [The importance of cardiac glycoside therapy. Digitalis--to use or not to use?]. Jerie P Ther Umsch; 1984 Feb; 41(2):96-102. PubMed ID: 6369617 [No Abstract] [Full Text] [Related]
14. Cardiac glycosides as novel cancer therapeutic agents. Newman RA; Yang P; Pawlus AD; Block KI Mol Interv; 2008 Feb; 8(1):36-49. PubMed ID: 18332483 [TBL] [Abstract][Full Text] [Related]
15. [Pharmacology of cardiotonic glycosides]. Berdeaux A Rev Prat; 1986 Oct; 36(43):2499-505. PubMed ID: 3787145 [No Abstract] [Full Text] [Related]
16. [Synthesis and properties of digitoxigenin-3 beta-O-alpha-L-arabinofuranoside]. Schwabe K; Tschiersch B Pharmazie; 1982 Dec; 37(12):827-8. PubMed ID: 6298840 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of action of the cardiac glycosides on the heart. Langer GA Biochem Pharmacol; 1981 Dec; 30(24):3261-4. PubMed ID: 6275858 [No Abstract] [Full Text] [Related]
18. A new alternative in the field of cardiac glycosides: gitoxin. Pellegrin P; Lesne M J Pharm Belg; 1986; 41(1):39-53. PubMed ID: 3009773 [No Abstract] [Full Text] [Related]
19. [A study of the kinetics of cardiac glycosides in the human organism]. van Zwieten PA Ned Tijdschr Geneeskd; 1971 Jan; 115(4):157-62. PubMed ID: 4926491 [No Abstract] [Full Text] [Related]
20. Studies on sodium-potassium-activated adenosinetriphosphatase. IV. Correlation with cation transport sensitive to cardiac glycosides. BONTING SL; CARAVAGGIO LL; HAWKINS NM Arch Biochem Biophys; 1962 Sep; 98():413-9. PubMed ID: 13871107 [No Abstract] [Full Text] [Related] [Next] [New Search]